ANUH PHARMA
ANUHPHR · NSE
79.74
+0.13 (+0.16%)
as of 29 Oct 2026 close
Open
81.50
High
81.50
Low
79.00
Prev close
79.61
52w high
99.50
08 Sept 2026
52w low
67.00
30 Mar 2026
VWAP
79.71
Delivery %
53.5%
of volume
Volume 48,010 · turnover ₹38.27 L · NSE bhavcopy (official close), adjusted for splits/bonuses · history since 20 Dec 2024
- ISIN
- INE489G01022
- Series
- EQ
- Listed on NSE
- 20 Dec 2024
- Face value
- ₹5
- F&O
- No
Source: NSE equity master · as of 30 Oct 2026
Daily · NSE EOD
Quarterly results · Standalone · latest 30 Sept 2026
filed 30 Oct 2026, 05:41 pm IST| ₹ crore | Sept 26* |
|---|---|
| Revenue | 185 |
| Other income | 1 |
| Total expenses | 171 |
| Operating margin | 9.1% |
| Finance costs | 0 |
| Depreciation | 2 |
| Profit before tax | 15 |
| Tax | 4 |
| Net profit | 11 |
| Net margin | 6.1% |
| EPS (₹) | 1.12 |
Source and definitions
NSE financial-results filings (XBRL / integrated filing). Figures exactly as filed with NSE in the company's results, converted to ₹ crore from the filing's own rounding. Operating margin = (PBT + finance costs + depreciation − other income) ÷ revenue. Net margin = net profit ÷ revenue. * = unaudited quarter. Consolidated figures are shown when the company files them; otherwise standalone.
Coming next in fundamentals
Arrives in Phase 2. Nothing here is estimated or filled in — we only show data we have.
- P/E, P/B, EV/EBITDA, ROE, ROCE (needs balance sheet + market cap)
- FII / DII / mutual fund split (from shareholding XBRL)
- Peer comparison